The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
Open accessAbstract
The pharmacology of the stable cell line expressing human α 4 β 3 δ GABA A receptor was investigated using whole‐cell patch‐clamp techniques. α 4 β 3 δ receptors exhibited increased sensitivity to GABA when compared to α 4 β 3 γ 2 receptors, with EC 50's of 0.50 (0.46, 0.53) μ M and 2.6 (2.5, 2.6) μ M respectively. Additionally, the GABA partial agonists piperidine‐4‐sulphonate (P4S) and 4,5,6,7‐tetrahydroisothiazolo‐[5,4‐c]pyridin‐3‐ol (THIP) displayed markedly higher efficacy at α 4 β 3 δ receptors, indeed THIP demonstrated greater efficacy than GABA at these receptors. The δ subunit conferred slow desensitization to GABA, with rate constants of 4.8±0.5 s for α 4 β 3 δ and 2.5±0.2 s for α 4 β 3 γ 2. However, both P4S and THIP demonstrated similar levels of desensitization on both receptor subtypes suggesting this effect is agonist specific. α 4 β 3 δ and α 4 β 3 γ 2 demonstrated equal sensitivity to inhibition by the cation zinc (2–3 μ M IC 50). However, α 4 β 3 δ receptors demonstrated greater sensitivity to inhibition by lanthanum. The IC 50 for GABA antagonists SR‐95531 and picrotoxin, was similar for α 4 β 3 δ and α 4 β 3 γ 2. Likewise, inhibition was observed on both subtypes at high and low pH. α 4 β 3 δ receptors were insensitive to modulation by benzodiazepine ligands. In contrast Ro15‐4513 and bretazenil potentiated GABA responses on α 4 β 3 γ 2 cells, and the inverse agonist DMCM showed allosteric inhibition of α 4 β 3 γ 2 receptors. The efficacy of neurosteroids at α 4 β 3 δ receptors was greatly enhanced over that observed at α 4 β 3 γ 2 receptors. The greatest effect was observed using THDOC with 524±71.6% potentiation at α 4 β 3 δ and 297.9±49.7% at α 4 β 3 γ 2 receptors. Inhibition by the steroid pregnenolone sulphate however, showed no subtype selectivity. The efficacy of both pentobarbitone and propofol was slightly augmented and etomidate greatly enhanced at α 4 β 3 δ receptors versus α 4 β 3 γ 2 receptors. We show that the α 4 β 3 δ receptor has a distinct pharmacology and kinetic profile. With its restricted distribution within the brain and unique pharmacology this receptor may play an important role in the action of neurosteroids and anaesthetics. British Journal of Pharmacology (2002) 136, 965–974. doi:10.1038/sj.bjp.0704795
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., & Sperk, G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00442-5 · Cited by 1,344
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., & Seeburg, P. H. (1989) · Nature · doi:10.1038/338582a0 · Cited by 1,293
Which GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Nusser, Z., Sieghart, W., & Somogyi, P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01693.1998 · Cited by 833
Brickley, S. G., Cull-Candy, S. G., & Farrant, M. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021806 · Cited by 717
GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/31948 · Cited by 564
Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z.-P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12905 · Cited by 520
Modulation of the GABA receptor complex by a steroid anaesthetic
Harrison, N. L., & Simmonds, M. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90299-3 · Cited by 499
Research works printed but not linked: 2
- 10.1016/S0014-2999(01)01558-8 · doi:10.1016/s0014-2999(01)01558-8
- SIEGHART W., 1995, Structure and function of γ‐aminobutyric acidA receptor subtypes, Pharmacol. Rev., 47, 181
Cited by
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
Stell, B. M., Brickley, S. G., Tang, C. Y., Farrant, M., & Mody, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435457100 · Cited by 797
Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Brickley, S. G., & Mody, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 676
Maguire, J. L., Stell, B. M., Rafizadeh, M., & Mody, I. (2005) · Nature Neuroscience · doi:10.1038/nn1469 · Cited by 644
Regulation and function of adult neurogenesis: from genes to cognition.
Aimone, J. B., Li, Y., Lee, S. W., Clemenson, G. D., Deng, W., & Gage, F. H. (2014) · Physiological Reviews · doi:10.1152/physrev.00004.2014 · Cited by 635
Naylor, D. E., Liu, H., & Wasterlain, C. G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4944-04.2005 · Cited by 548
Neurosteroid modulation of GABAA receptors
Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., & Peters, J. A. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.001 · Cited by 493
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
“…conveys properties ideally suited to generating tonic inhibition, namely activation by low concentrations of GABA, such as may be found in the extracellular space and reduced desensitization (Saxena and Macdonald, 1994; Haas and Macdonald, 1999; Bianchi and Macdonald, 2002; Brown et al., 2002).”
BackgroundInfluentialMolecular Targets for Antiepileptic Drug Development
Meldrum, B. S., & Rogawski, M. A. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 468
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435171100 · Cited by 462
GABAA Receptor Trafficking-Mediated Plasticity of Inhibitory Synapses
Luscher, B., Fuchs, T., & Kilpatrick, C. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.024 · Cited by 434
The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progress
Kumar, S., Porcu, P., Werner, D. F., Matthews, D. B., Diaz-Granados, J. L., Helfand, R. S., & Morrow, A. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1562-z · Cited by 431
GABAA receptors: structure, function, pharmacology, and related disorders
Ghit, A., Assal, D., Al-Shami, A. S., & Hussein, D. E. E. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00224-0 · Cited by 405
GABAA receptor diversity and pharmacology
Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 363
Activation of GABAA Receptors: Views from Outside the Synaptic Cleft
Glykys, J., & Mody, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.002 · Cited by 358
Wei, W., Zhang, N., Peng, Z., Houser, C. R., & Mody, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10650.2003 · Cited by 359
Dibbens, L. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh146 · Cited by 346
The influence of subunit composition on the interaction of neurosteroids with GABAA receptors
Belelli, D., Casula, A., Ling, A., & Lambert, J. J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00172-7 · Cited by 334
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
Whiting, P. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02703-x · Cited by 326
Self-citationSubunit-Specific Trafficking of GABAAReceptors during Status Epilepticus
Goodkin, H. P., Joshi, S., Mtchedlishvili, Z., Brar, J., & Kapur, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3426-07.2008 · Cited by 322
Altered Expression of the δ Subunit of the GABAAReceptor in a Mouse Model of Temporal Lobe Epilepsy
Peng, Z., Huang, C. S., Stell, B. M., Mody, I., & Houser, C. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2877-04.2004 · Cited by 321
Cagetti, E., Liang, J., Spigelman, I., & Olsen, R. W. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.53 · Cited by 320
Chandra, D., Jia, F., Liang, J., Peng, Z., Suryanarayanan, A., Werner, D. F., Spigelman, I., Houser, C. R., Olsen, R. W., Harrison, N. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604304103 · Cited by 314
GABA A Receptor-Mediated Tonic Inhibition in Thalamic Neurons
Cope, D. W., Hughes, S. W., & Crunelli, V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3362-05.2005 · Cited by 312
Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., & Huntsman, M. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1714-10.2010 · Cited by 309
Wu, Z., Guo, Z., Gearing, M., & Chen, G. (2014) · Nature Communications · doi:10.1038/ncomms5159 · Cited by 306
The Role of GABA in the Mediation and Perception of Pain
Enna, S. J., & McCarson, K. E. (2006) · Advances in Pharmacology · doi:10.1016/s1054-3589(06)54001-3 · Cited by 284
GABAA Receptor Channel Pharmacology
Johnston, G. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054021024 · Cited by 274
Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic α-Cells
Ravier, M. A., & Rutter, G. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1789 · Cited by 264
Wendt, A., Birnir, B., Buschard, K., Gromada, J., Salehi, A., Sewing, S., Rorsman, P., & Braun, M. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1038 · Cited by 259
Sarkar, J., Wakefield, S., MacKenzie, G., Moss, S. J., & Maguire, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2560-11.2011 · Cited by 254
The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus
Glykys, J., & Mody, I. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.134460 · Cited by 253
Dias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247
Self-citationLee, V., & Maguire, J. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00003 · Cited by 228
Mechanisms of Inhibition within the Telencephalon: “Where the Wild Things Are”
Fishell, G., & Rudy, B. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113717 · Cited by 233
Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors
Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206
Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188
Self-citationNeurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180
Lambert, J. J., Belelli, D., Harney, S. C., Peters, J. A., & Frenguelli, B. G. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00124-2 · Cited by 164
Gunn, B. G., Cunningham, L., Cooper, M. A., Corteen, N. L., Seifi, M., Swinny, J. D., Lambert, J. J., & Belelli, D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1337-13.2013 · Cited by 151
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response
Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149
Locci, A., & Pinna, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13843 · Cited by 132
Maguire, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00083 · Cited by 113
“These specific subtypes of GABAARs have also been shown to be particularly sensitive to neurosteroid modulation (Mihalek et al., 1999; Belelli et al., 2002; Brown et al., 2002; Wohlfarth et al., 2002; Spigelman et al., 2003).”
BackgroundAllopregnanolone-based treatments for postpartum depression: Why/how do they work?
Walton, N., & Maguire, J. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100198 · Cited by 103
“Extrasynaptically localized δ subunit-containing receptors have been shown to confer neurosteroid sensitivity (Belelli et al., 2002; Brown et al., 2002; Mihalek et al., 1999; Spigelman et al., 2002; Wohlfarth et al., 2002); however, the neurosteroid binding site has been localized to the αsubunit transmembrane domain…”
GABAergic regulation of the HPA and HPG axes and the impact of stress on reproductive function
Camille Melón, L., & Maguire, J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.11.019 · Cited by 94
GABAA receptor subtypes underlying general anesthesia
Bonin, R. P., & Orser, B. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.011 · Cited by 85
Role of GABAA receptors in cognition
Möhler, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371328 · Cited by 79
Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
Belelli, D., Hogenkamp, D., Gee, K. W., & Lambert, J. J. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100207 · Cited by 67
Yu, J., Proddutur, A., Elgammal, F. S., Ito, T., & Santhakumar, V. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00891.2012 · Cited by 62
“In some experiments, 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP, 1 M), a selective GABAAR agonist with a preference for -subunit-containing GABAARs (Brown et al. 2002), or the GABA transporter-1 uptake inhibitor 1-[2-[[(diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid hydrochlo…”
BackgroundResultInfluentialEffect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors
Picton, A. J., & Fisher, J. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.050 · Cited by 61
Kaura, V., Ingram, C. D., Gartside, S. E., Young, A. H., & Judge, S. J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.006 · Cited by 44
Sabaliauskas, N., Shen, H., Molla, J., Gong, Q. H., Kuver, A., Aoki, C., & Smith, S. S. (2015) · Brain Research · doi:10.1016/j.brainres.2014.12.026 · Cited by 39
Rewal, M., Donahue, R., Gill, T. M., Nie, H., Ron, D., & Janak, P. H. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00333.x · Cited by 34
Plasticity and function of extrasynaptic GABAA receptors during pregnancy and after delivery
Mostallino, M. C., Sanna, E., Concas, A., Biggio, G., & Follesa, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.013 · Cited by 32
Lanir-Azaria, S., Meiri, G., Avigdor, T., Minert, A., & Devor, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.035 · Cited by 20
Melón, L. C., Nolan, Z. T., Colar, D., Moore, E. M., & Boehm, S. L. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.07.015 · Cited by 18
Fritz, B. M., & Boehm II, S. L. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.020 · Cited by 10
Metadata
- Authors
- Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 136
- Issue
- 7
- Pages
- 965-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2061947653
- Cited by
- 603
- References
- 38
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.